Imperial Enterprise’s Post

What do you think is required to enable the next generation of neural implants? MintNeuro might just have the answer after securing their first external funding round to develop their innovative semiconductor-based approach for neural implants. Traditional treatments for neurological disorders, like pharmaceuticals, often fall short. Developed at Imperial College London MintNeuro’s scalable, low-power chips are transforming the possibilities of neural implants by making them smaller, more efficient, and accessible for a wider range of neurological conditions. Empirical Ventures is proud to have led this round alongside Parkwalk Advisors, Imperial College London and Plug and Play Tech Center. This funding will accelerate MintNeuro’s chip development and allow it to grow its expert team. The potential is vast: from monitoring epilepsy to treating Parkinson's, dementia, and beyond. The neural implant market is expected to expand rapidly, and we’re proud to support entrepreneurial scientists like MintNeuro's Dorian Haci, PhD and Timothy Constandinou as they pioneer a new era of neurological care. Congratulations to the MintNeuro team, and here’s to reshaping the future of neural technology! #Investment #NeuroTech #Innovation #HealthcareTech #EmpiricalVentures CAPITAL AT RISK FOR PROFESSIONAL INVESTORS ONLY. https://lnkd.in/earKiCZN

There ya have it folks... Talk about losing your head. World’s first head transplant system unveiled Neuroscience and biomedical engineering startup BrainBridge has announced its ambitious goal to develop the world’s first head transplant system. The company, which had been operating in stealth mode, revealed that it is integrating advanced robotics and artificial intelligence to execute complete head and face transplantation procedures, a concept reminiscent of science fiction but now inching closer to reality. BrainBridge’s pioneering technology aims to offer new hope to patients suffering from untreatable conditions such as stage-4 cancer, paralysis, and neurodegenerative diseases like Alzheimer’s and Parkinson’s. The procedure involves transplanting a patient’s head onto a healthy, brain-dead donor body, with the aim of preserving consciousness, memories, and cognitive abilities. The company plans to employ high-speed robotic systems to prevent brain cell degradation and ensure seamless compatibility between the transplanted head and donor body. Real-time molecular-level imaging and advanced AI algorithms will guide the precise reconnection of the spinal cord, nerves, and blood vessels. BrainBridge’s integrated robotics platform features two autonomous surgical robots designed to perform simultaneous surgeries on two bodies within a single setup. The company’s proprietary chemical adhesive, polyethylene glycol, will aid in reconnecting severed neurons. Additionally, a specialized implant placed in the epidural space behind the spine will promote neuron repair, enabling the patient’s brain to form neural connections with the new body. The BCI-equipped BrainBridge Head Band will allow patients to communicate their needs during recovery. If you enjoy my posts, find them EDucational and can find in your heart to contribute to my grandsons cause it would be greatly appreciated. I have included the gofundme link here: https://gofund.me/f976d125 paypal email is: Edward Davidson ewdjr7@gmail.com @EDavidson007 cashapp: https://lnkd.in/gi56HwpW venmo is : Ed Davidson ewdjr7@gmail.com @Ed-Davidson-6 GiveSendGo: https://lnkd.in/gKUB9h6i zelle: ewdjr7@gmail.com #eddavidson #culture #money #management #innovation #brandmarketing #technology #creativity #digitalamarketing #futurism #thereyahaveit #socialmedia #socialnetworking #marketing #venturecapital #motivation

✨ B-CRATOS Focus on BCI - Tackling Health Challenges to Improve Quality of Life?✨ 🎉 Big news for a startup at Rice University in the US, raising nearly 19 million USD to move ahead with a neural stimulator to treat depression! What is particularly exciting about their innovative approach is that they are "less invasively" stimulating the cortex, without making direct contact with neural tissue. And of course, as with most "brain implants of the future", we see that this device is wirelessly charged and fully implantable. This is the payoff from over 10 years of research at Rice! At B-CRATOS, we are particularly excited to see such developments as they support the strategy of pushing wireless technologies forward to boost the impact of neural implantables. The Rice device may be focused on stimulation for now, but one can imagine future iterations focusing on readout and data capture to improve the therapy 🔔 To know more about #BCI, join us at our free webinar the 11th of March with Paul W. from Blackrock Microsystems Europe! You can already register ➡ https://lnkd.in/e7Fst8RZ https://lnkd.in/g73e69mk

MintNeuro, a pioneer in low-power semiconductor technology for minimally invasive neural implants, has raised £1 million in a funding round led by Empirical Ventures, with support from Parkwalk Advisors, Imperial College London, Plug and Play Tech Center, Excellis, and Angel Investors. Neurological disorders impact over a billion people globally, but current treatments, especially drugs, often lack effectiveness. Neural implants present an alternative, though existing options are typically bulky, power-hungry, and require invasive surgery. MintNeuro, spun out of Imperial College London, addresses these issues by using advanced semiconductor technology to create compact, energy-efficient, and scalable neural devices adaptable to a range of conditions. “Our semiconductor-based approach redefines the capabilities of neural implants,” said Timothy Constandinou, CTO and co-founder of MintNeuro. “With a customizable, compact solution, we’re advancing powerful yet minimally invasive neural interfaces—a transformative step in neurological care.” Dorian Haci, PhD, CEO and co-founder, added, “Millions face limited treatment options. Our goal is to bridge that gap with safer, more accessible technology. This funding accelerates our progress, bringing impactful neural implants to clinicians for patient benefit worldwide.” Congratulations to the MintNeuro team! #neuralinterface #neurotech #neuralimplant #neurotech

Will it work ?

Join Mantis Photonics Revolution in Early Medical Diagnosis!  🔗 Visit & Invest in our crowdfunding campaign : https://lnkd.in/dg9s6eNB Our mission? 💡 Transform early diagnosis with hyperspectral retinal imaging. 🌍 Impact: Diagnose diseases like Alzheimer and AMD early, reducing treatment costs. 🚫 Current diagnostic techniques: Invasive & costly. 🎯 Our Solution: Non-invasive, compact hyperspectral tech for HCPs and caregivers at point-of-care. Benefits for you? 📊 Minimum ticket €500, potential ROI: x11 in 4 years. 🤝 Be part of a groundbreaking tech, impact lives & lessen healthcare burdens. 📋 Current Progress: Developed prototype, received intent letters from medical pros, Clinical validation for AMD diagnostic. 💻 Contact us: Dive deeper & answer your queries. denis.hellebuyck@mantis-photonics.com #InvestInMantisPhotonics #TransformHealthcare #EarlyDiagnosisRevolution #TheEyeIsTheWindowToYourHealth #Startup #HyperspectralCamera #OphthalmologicDiseases #NeurologicalDisorders #AMD #Glaucoma #Naevi #Alzheimer

🤖 Built upon a decade-long legacy of robotic ultrasonography products, today NeuraSignal is focused on taking its FDA-cleared NovaGuide platform to market. Currently, only around 8% of hospitals that treat stroke utilize TCD, as it must be performed by a trained neurovascular sonographer. NeuraSignal CEO Robert Hamilton, PhD estimates that there are between 200 and 300 comprehensive stroke centers in the US, with primary stroke centers ranking just below them in terms of prestige, surgical capability, and revenue generation. With its NovaGuide platform, NeuraSignal aims to equip more institutions with automated TCD technology, so they may be able to detect disease states earlier than the current standard of care:  https://bit.ly/3PikSSH #medtech #medicaldevices #startups #strokecare #robotics #neurology #brainhealth

It's Sunday! Some may have football on the mind, but I am thinking about #Medtech and the exciting week we had... My partner Ajay Nair attended #arabhealth2024 and returned energized. Check his posts for highlights. Joe Mullings hit #MDMWest2024, a great event in our industry highlighting its backbone, contract partners of #medicaldevices Vektor Medical, Inc. announced a nice $16 Mil Series A, allowing for expanded reach of their non-invasive #AI based arrhythmia analysis solution, big win in this significant market opportunity Robert J. Krummen Mirai Medical secured funding towards Series A for their #cancer therapy treatment Declan Soden, and DASI Simulations secured an additional $5 Mil towards their #structuralheart planning tool Teri Sirset Lakshmi Dasi Procyrion, Inc. raised almost $58 Mil in a Series E for their percutaneous mechanical circulatory support #pMCS device for #ADHF #heartfailure patients, great progress Eric Fain Dexcom expects revenue growth of 20% in 2024, including projected revenues between $4.15 billion and $4.35 billion. Especially notable given their track record of success to date, strong progress for #diabetes management Subhan K. Girish Naganathan Kevin Sayer Important partnerships announced between Exactech and Statera Medical for a smart shoulder implant Samuel Bourdon, P. Eng, BodyVision and HugeMed South Asia for their #pulmonary platform, and Interventional Systems and Gulf Horizon Co. Ltd. for product positioning technology David Webster Pedro Costa Jeffrey Binder Microbot Medical submitted their #surgicalrobotics device for #FDA #IDE Harel Gadot, ORTHOSON Ltd announced its bio-gel has been granted #BDD Rich Simmonds, and Edwards Lifesciences had their #tricuspid valve technology approved earlier than expected based on strong clinical data BariaTek, innovator of #MIS #obesity technology, initiated its #FIH trial Youssef Biadillah Dilon Technologies Inc. started trial for their next gen #lumpectomy device George Makhoul ShiraTronics, Inc. completed pilot trial for migrane therapy Rob Binney FEops shared positive data on left atrial appendage tech Matthieu De Beule Innova Vascular, Inc. reported positive data on #thrombectomy system Sanjay Shrivastava, Ph.D. The most interesting story of the week is a cautionary tale. The #neurotechnology market holds incredible possibilities for treatments across many challenging disorders, and interest in this space is validated by its record investment in 2023 (1.4 Bil, almost double 2022). However, there is question around clinical trial design, safety and transparency of the Neuralink study. The lack of trial registration on ClinicalTrials.gov begs the question of ethical principles protecting volunteers for these trials. Elon Musk has made news for many unconventional actions, let's ensure the right guardrails are in place with leadership scope outside his area of expertise. https://lnkd.in/eakEThBK

#Neuralink's first human implant Elon Musk, the billionaire founder of Neuralink, announced that the first human implant of the company's brain-computer interface (BCI) device took place on Sunday, and the patient is currently recovering. The initial results of the implantation are promising, showing neuron spike detection. Neuralink's first human clinical trial, known as the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), aims to evaluate the safety and functionality of the N1 implant, which is designed to enable people with quadriplegia to control devices with their thoughts The N1 implant is cosmetically invisible once placed and uses 1,024 electrodes distributed across 64 threads, each thinner than a human hair, to record and transmit brain signals wirelessly to an app that decodes them[3][6]. The implant is surgically placed into a part of the brain that controls movement by a robot called the R1 Robot. The study is being conducted under the investigational device exemption (IDE) awarded by the U.S. Food and Drug Administration (FDA). Neuralink's BCI technology is intended to help people with paralysis control technology devices such as computer cursors or keyboards and may have the potential to restore full body movement and other functions in the future. The company has not disclosed the exact region of the brain where the device will be embedded, the hospital that has given institutional review board approval, or the number of participants that will be enrolled in the study. Interested individuals with quadriplegia due to cervical spinal cord injury or amyotrophic lateral sclerosis (ALS) can sign up for the patient registry on Neuralink's website.

INBRAIN Neuroelectronics, a Barcelona-based startup, has developed a novel brain implant made of #graphene, which will undergo its first human trials this summer. This #braincomputerinterface (#BCI) technology is designed to both record and stimulate brain activity, overcoming limitations of traditional metallic BCIs caused by Faradaic reactions that degrade their effectiveness. The chip features “graphene dots” for high-resolution signal decoding and precise brain stimulation. The initial trial at The University of Manchester will assist in #braintumor resection, aiming to improve surgical precision while preserving brain functions. The chip can decode movement intentions and Parkinson’s-related #biomarkers, potentially optimizing drug regimens and reducing medication needs by up to 50%. The chip has received #FDAbreakthrough designation for #Parkinsonsdisease therapy. Link: https://lnkd.in/eQrBeRC5